Mahmoud Sarmini, MD
Physical Medicine & Rehabilitation · New Orleans, LANPI 1770505786
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Tanabe Pharma America, Inc. at 38.5% of the total.
Across 17 payments — averaging $30.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tanabe Pharma America, Inc.$202
- Alnylam Pharmaceuticals Inc.$93
- Novartis$72
- Amgen$48
- Virtus Pharmaceuticals LLC$40
- Johnson & Johnson$36
- plus $32 from 1 others
What the payments were for
- Food & beverage$523100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tanabe Pharma America, Inc. | 9 | $202 |
| Alnylam Pharmaceuticals Inc. | 1 | $93 |
| Novartis | 1 | $72 |
| Amgen | 2 | $48 |
| Virtus Pharmaceuticals LLC | 2 | $40 |
| Johnson & Johnson | 1 | $36 |
| Amylyx Pharmaceuticals, Inc. | 1 | $32 |
How this compares
$523 in reported general payments places this provider in the 60th percentile of 117 physical medicine & rehabilitation providers in Louisiana.
See all physical medicine & rehabilitation providers in Louisiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 2,046 | $61,038 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,463 | $49,557 |
| SavellaMilnacipran Hcl | 52 | $36,145 |
| OxycontinOxycodone Hcl | 36 | $30,587 |
| Gabapentin | 1,507 | $29,116 |
| Oxycodone Hcl | 775 | $20,609 |
| Lidocaine | 124 | $17,917 |
| LinzessLinaclotide | 14 | $10,273 |
| Pregabalin | 582 | $10,270 |
| Morphine Sulfate ErMorphine Sulfate | 239 | $10,211 |
| Duloxetine Hcl | 597 | $8,923 |
| Tramadol Hcl | 801 | $7,870 |
| Diclofenac Sodium | 184 | $6,564 |
| Tizanidine Hcl | 424 | $6,089 |
| MovantikNaloxegol Oxalate | 14 | $5,803 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in New Orleans
- Eric FinckeNew Orleans$9K
- Casey MurphyNew Orleans$8K
- Joshua KaufmanNew Orleans$8K
- Brandon HicksNew Orleans$7K
- Ariean Loo-HernandezNew Orleans$4K
- Jonathan FinneyNew Orleans$2K
- Jeffrey WatkinsNew Orleans$2K
- Michael ConnorsNew Orleans$1K
- Zachary RichardNew Orleans$880
- Ethan RaultNew Orleans$707
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.